Could skipping the breathing tube make esophageal cancer surgery safer?
NCT ID NCT07104838
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a laryngeal mask instead of a breathing tube during esophageal cancer surgery can reduce complications and speed up recovery. About 500 adults with resectable esophageal cancer will be randomly assigned to one of two anesthesia methods. The goal is to see if the non-intubated approach is as safe and effective as the standard method.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 75 years * Diagnosed with resectable middle or lower thoracic esophageal squamous cell carcinoma or adenocarcinoma (clinical stage I-III) * Scheduled to undergo thoracoscopic esophagectomy * American Society of Anesthesiologists (ASA) score ≤ III * Eastern Cooperative Oncology Group (ECOG) performance status ≤ 1 * Preoperative pulmonary function test with FEV₁ ≥ 50% predicted * Written informed consent obtained Exclusion Criteria: * Severe risk of aspiration due to reflux, gastric retention, or hiatal hernia * Body mass index (BMI) ≥ 30 kg/m² * Extensive pleural adhesions discovered preoperatively * History of upper thoracic or intrathoracic surgery * Pregnancy or lactation * Known allergy or intolerance to anesthetic agents
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Esophageal adenocarcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Antibody-Drug conjugate targets advanced esophageal cancer after standard treatments fail
- Swallowable capsule and lab test take on endoscopy for esophageal cancer screening
- Can a drug combo stop esophageal cancer from returning after surgery?
- Experimental drug put to the test against Hard-to-Treat GI cancers
- Can a drug combo shrink esophageal tumors before surgery?
- Can a direct hit to tumors make immunotherapy work better?